Investigating the Impact of Using an Alternate Classification Method for Race and Hispanic Ethnicity on Rates of Reported Gonorrhea.


Journal

Sexually transmitted diseases
ISSN: 1537-4521
Titre abrégé: Sex Transm Dis
Pays: United States
ID NLM: 7705941

Informations de publication

Date de publication:
11 2020
Historique:
pubmed: 3 8 2020
medline: 7 4 2021
entrez: 3 8 2020
Statut: ppublish

Résumé

We aimed to examine how the classification of gonorrhea cases by race and Hispanic ethnicity (HE) affects the measurement of racial/HE disparities in the rates of reported gonorrhea. We examined gonorrhea cases reported through the National Notifiable Diseases Surveillance System from January 1, 2010, to December 31, 2017, and assigned race and HE using (1) "current classification," where cases with HE are classified as Hispanic regardless of race (e.g., Hispanic, non-Hispanic White, and non-Hispanic Black), and 2) "alternate classification," which separates each race category by HE (e.g., Hispanic White and non-Hispanic White). We estimated annual gonorrhea rates during 2010 to 2017 by race/HE category and calculated disparity measures (index of disparity, population-attributable proportion, and Gini coefficient) for gonorrhea rates under each classification strategy. All disparity measures revealed decreases in racial/HE disparities in the rates of reported gonorrhea during 2010 to 2017, regardless of classification strategy; however, the magnitude of the disparity and the percent change in the disparity over time varied across disparity measures. Understanding how classification of race/HE affects observed disparities is critical when monitoring interventions to reduce disparities and improve health equity.

Sections du résumé

BACKGROUND
We aimed to examine how the classification of gonorrhea cases by race and Hispanic ethnicity (HE) affects the measurement of racial/HE disparities in the rates of reported gonorrhea.
METHODS
We examined gonorrhea cases reported through the National Notifiable Diseases Surveillance System from January 1, 2010, to December 31, 2017, and assigned race and HE using (1) "current classification," where cases with HE are classified as Hispanic regardless of race (e.g., Hispanic, non-Hispanic White, and non-Hispanic Black), and 2) "alternate classification," which separates each race category by HE (e.g., Hispanic White and non-Hispanic White). We estimated annual gonorrhea rates during 2010 to 2017 by race/HE category and calculated disparity measures (index of disparity, population-attributable proportion, and Gini coefficient) for gonorrhea rates under each classification strategy.
RESULTS
All disparity measures revealed decreases in racial/HE disparities in the rates of reported gonorrhea during 2010 to 2017, regardless of classification strategy; however, the magnitude of the disparity and the percent change in the disparity over time varied across disparity measures.
CONCLUSIONS
Understanding how classification of race/HE affects observed disparities is critical when monitoring interventions to reduce disparities and improve health equity.

Identifiants

pubmed: 32740448
doi: 10.1097/OLQ.0000000000001255
pii: 00007435-202011000-00001
pmc: PMC9039986
mid: NIHMS1798170
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

717-723

Subventions

Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

MMWR Morb Mortal Wkly Rep. 2017 Feb 03;66(4):104-106
pubmed: 28151925
Public Health Rev. 2016 Dec 7;37:31
pubmed: 29450072
Sex Transm Dis. 2012 Jun;39(6):458-64
pubmed: 22592832
Sex Transm Dis. 2008 Dec;35(12 Suppl):S40-4
pubmed: 18836391
Am J Public Health. 2013 May;103(5):910-6
pubmed: 23488482
Sex Transm Dis. 2013 Jun;40(6):439-43
pubmed: 23677016
Sex Transm Dis. 2004 Mar;31(3):149-53
pubmed: 15076926
BMJ. 1997 Jun 14;314(7096):1703-4
pubmed: 9202498
Sex Transm Dis. 2017 Sep;44(9):513-518
pubmed: 28809767
Public Health Rep. 2002 May-Jun;117(3):273-80
pubmed: 12432138
PeerJ. 2020 Jan 20;8:e8434
pubmed: 31998566
J Acquir Immune Defic Syndr. 2019 May 1;81(1):57-62
pubmed: 30964805
Sex Transm Dis. 2018 Oct;45(10):703-705
pubmed: 29624561
Sex Transm Dis. 2016 Nov;43(11):661-667
pubmed: 27893593
Sex Transm Dis. 2008 Dec;35(12 Suppl):S13-8
pubmed: 18936725
BMJ. 2018 Feb 22;360:k757
pubmed: 29472187
J Epidemiol Community Health. 2004 Nov;58(11):900-3
pubmed: 15483304
Sex Transm Infect. 2010 Dec;86 Suppl 3:iii52-57
pubmed: 21098057
BMJ. 1997 Jun 14;314(7096):1751-6
pubmed: 9202509

Auteurs

Harrell Chesson (H)

From the Division of STD Prevention, Centers for Disease Control and Prevention.

Jimmy Braxton (J)

From the Division of STD Prevention, Centers for Disease Control and Prevention.

Elizabeth Torrone (E)

From the Division of STD Prevention, Centers for Disease Control and Prevention.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH